Renaissance Technologies’s MDxHealth MDXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$701K Buy
304,700
+54,600
+22% +$185K ﹤0.01% 2441
2025
Q4
$893K Buy
250,100
+47,300
+23% +$187K ﹤0.01% 2344
2025
Q3
$943K Buy
202,800
+57,527
+40% +$177K ﹤0.01% 2510
2025
Q2
$321K Buy
145,273
+23,073
+19% +$43.3K ﹤0.01% 3020
2025
Q1
$174K Sell
122,200
-900
-0.7% -$1.63K ﹤0.01% 3105
2024
Q4
$292K Buy
123,100
+108,000
+715% +$221K ﹤0.01% 3050
2024
Q3
$31.4K Buy
+15,100
New +$41K ﹤0.01% 3393
2024
Q1
Sell
-18,300
Closed -$72K 3927
2023
Q4
$72K Buy
+18,300
New +$54.8K ﹤0.01% 3382
2023
Q3
Sell
-29,700
Closed -$101K 3924
2023
Q2
$101K Buy
+29,700
New +$109K ﹤0.01% 3467

Other funds holding MDXH

Renaissance Technologies's MDXH Position: Q1 2026 in Review

Renaissance Technologies increased its MDxHealth (MDXH) stake by 22% in Q1 2026, buying an estimated $185K and bringing the position to 304,700 shares worth $701K. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

Renaissance Technologies first reported a position in MDXH in Q2 2023 and has held it in 9 quarters since. The position peaked at $943K in Q3 2025. 51 funds tracked by Wall St. Rank hold MDXH as of Q1 2026.

  • Renaissance Technologies held 304,700 shares of MDxHealth worth $701K as of Q1 2026.
  • Renaissance Technologies bought 54,600 MDxHealth shares in Q1 2026, an estimated $185K.
  • MDxHealth made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2441 holding.
  • Renaissance Technologies first reported a position in MDxHealth in Q2 2023 and has held it in 9 quarters since.
  • Renaissance Technologies's MDxHealth position peaked at $943K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held MDxHealth as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.